Assertio Therapeutics, Inc Purchase Agreements
10 Contracts & Agreements
- Asset Purchase Agreement, dated February 6, 2020, by and between Assertio Therapeutics Inc. and Collegium Pharmaceutical, Inc (Filed With SEC on February 20, 2020)
- Asset Purchase Agreement, dated February 6, 2020, by and between Assertio Therapeutics Inc. and Collegium Pharmaceutical, Inc (Filed With SEC on February 7, 2020)
- Asset Purchase Agreement, dated December 11, 2019, by and among Assertio Therapeutics Inc., Golf Acquiror LLC and, solely for the purposes set forth therein, Celtic Intermediate... (Filed With SEC on December 12, 2019)
- Amendment No. 1 to Royalty Purchase and Sale Agreement and Bill of Sale, dated August 2, 2018, by and among Depomed, Inc., Depo DR Sub, LLC, and PDL Investment Holdings, LLC (as... (Filed With SEC on August 8, 2018)
- ASSET PURCHASE AGREEMENT between Janssen Pharmaceuticals, Inc. and Depomed, Inc. DATED AS OF JANUARY 15, 2015 (Filed With SEC on February 26, 2015)
- ASSET PURCHASE AGREEMENT by and between NAUTILUS NEUROSCIENCES, INC., as Seller and DEPOMED, INC., as Purchaser Dated as of December 17, 2013 (Filed With SEC on March 17, 2014)
- ROYALTY PURCHASE AND SALE AGREEMENT dated as of October 18, 2013 between DEPOMED, INC., DEPO DR SUB, LLC, as Seller, and PDL BIOPHARMA, INC., as Purchaser (Filed With SEC on March 17, 2014)
- ASSET PURCHASE AGREEMENT by and among ARCHIMEDES PHARMA US INC., ARCHIMEDES PHARMA LTD., ARCHIMEDES DEVELOPMENT LTD. and DEPOMED, INC. July 29, 2013 (Filed With SEC on November 7, 2013)
- ASSET PURCHASE AGREEMENT by and between DEPOMED, INC. and XANODYNE PHARMACEUTICALS, INC. Dated as of June 21, 2012 (Filed With SEC on August 3, 2012)
- DEPOMED,INC. SECURITIESPURCHASE AGREEMENT April 21,2003 DEPOMED,INC. SECURITIES PURCHASE AGREEMENT (Filed With SEC on April 25, 2003)
